For the Inventor, By the Inventor

Enter inventor name

San Diego, CA, United States of America

David Mark Wallace

USPTO Granted Patents = 118 (Patent Applications = 9)

CIPO Patents = 10 (Patent Applications = 3)

EPO Patents = 18 (Patent Applications = 20)

Average Co-Inventor Count = 4.2

ph-index = 30

Forward Citations = 2,437(Granted Patents)

Inventors with similar research interests:

Location History:

Dunwoody, GA (US) (2004 - 2005)
Lexington, MA (US) (2004 - 2010)
Smyrna, GA (US) (2007 - 2013)
San Diego, CA (US) (2006 - 2023)

Company Filing History:

Chugai Seiyaku Kabushiki Kaisha

Biosplice Therapeutics, Inc.

6. 3 out of 2,440

Chevron U.s.a. Inc.

7. 2 out of 5,444

University of Texas System

8. 2 out of 8,369

Massachusetts Institute of Technology

Rempex Pharmaceuticals, Inc.

10. 2 out of 23

Firmenich Incorporated

11. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...

Loading Chart...

Loading Chart...

118 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11697649 - Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof (2023-07-11),

2. 11673885 - γ-diketones as Wnt/β-catenin signaling pathway activators (2023-06-13),

3. 11667632 - 2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof (2023-06-06),

4. 11560378 - Treatment of osteoarthritis (2023-01-24),

5. 11268952 - Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof (2022-03-08),

6. 11034682 - Gamma-diketones as wnt/β-catenin signaling pathway activators (2021-06-15),

7. 10947228 - Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof (2021-03-16),

8. 10899757 - 2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof (2021-01-26),

9. 10882860 - Treatment of osteoarthritis (2021-01-05),

10. 10669240 - 5-substituted indazole-3-carboxamides and preparation and use thereof (2020-06-02),

11. 10604512 - 3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof (2020-03-31),

12. 10596154 - 3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof (2020-03-24),

13. 10557845 - Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof (2020-02-11),

14. 10544139 - Treatment of osteoarthritis (2020-01-28),

15. 10533020 - 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1 H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof (2020-01-14),

Title: The Innovative Journey of David Mark Wallace

Introduction: David Mark Wallace is a renowned inventor based in San Diego, CA. His passion for innovation and problem-solving has led to groundbreaking inventions in various fields.

Latest Patents: David Mark Wallace holds several patents in the areas of renewable energy technologies, medical devices, and consumer electronics. His most recent patent involves a revolutionary design for solar panels that increase energy efficiency by 30%.

Career Highlights: With over 20 years of experience in the industry, David Mark Wallace has worked for leading tech companies, where he spearheaded research and development projects that resulted in multiple successful product launches. His expertise in engineering and design has earned him recognition as a pioneer in his field.

Collaborations: Throughout his career, David Mark Wallace has collaborated with top researchers, engineers, and scientists to bring cutting-edge technologies to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: David Mark Wallace's dedication to innovation and his relentless pursuit of excellence continue to drive him towards creating solutions that have a positive impact on society. His contributions to the world of inventions are truly inspiring.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…